Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

First International Society for Preclinical Research Quality Systems Launched

13th April 202212th April 2022

Guarantors of EQIPD to host platform and certification process to boost innovation NEW YORK, April

Mobilise-D project update: New webinars announced, prior ones published & WP2 conclusion

13th April 202212th April 2022
Mobilise-D - Logo Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

The Innovative Medicines Initiative (IMI) funded Mobilise-D project had the first five public webinars as

First national follow-on study to the EPAD Longitudinal Cohort Study launches

12th April 2022
3 EPAD 800x535 European Prevention of Alzheimer's Dementia Consortium

The European Prevention of Alzheimer’s Dementia (EPAD) project announces that the first study participant for

Alzheimer’s Disease Data Initiative ADDI NeuroToolKit Data Hackathon

6th April 2022

ADDI is calling on experts from around the world to join them in a two-week

Neuronet convenes 8th meeting of its Scientific Coordination Board

1st April 20221st April 2022

On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

Neuronet hosts meetings of its Patient Privacy & Ethics and Data Sharing working groups

30th March 2022
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

Neuronet is an Innovative Medicines Initiative (IMI)-funded coordination and support action, designed to support and

RADAR-CNS celebrates six years of achievements in its final meeting

1st April 202217th March 2022
RADAR-CNS logo

The RADAR-CNS team has held its final project meeting to mark the end of the

Spotlight on early-career researchers: a Neuronet interview with Ilaria Ottonelli

16th March 202215th March 2022
Spotlight on Early-Career researchers a Neuronet interview with Ilaria Ottonelli 2

Ilaria Ottonelli studies innovative nanomedicines for brain and retinal targeting at the University of Modena and Reggio Emilia.

The third annual RADAR-AD consortium meeting gathers over 50 project members

20th April 202215th March 2022
RADAR-AD Remote assessment of disease and relapse – Alzheimer’s disease

Once a year, RADAR-AD project members from different work streams, patient representatives and scientific advisors

Neuronet publishes series of project introduction videos during Brain Awareness Week

20th April 202214th March 2022

The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines

Post navigation
Older posts
Newer posts
← Previous Page1 … Page3 Page4 Page5 … Page29 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT